REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kern es Tarsai Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KERN es TARSAI Egeszsegugyi Szolgaltato Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Kern es Tarsai Bt. is an enterprise in Hungary, with the main office in Budapest. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on June 23, 1993. 4 (2023) employees currently work for Kern es Tarsai Bt.. In 2022, the company reported a net sales revenue increase of 7.1%. Its’ total assets recorded a negative growth of 8.84%. Kern es Tarsai Bt.’s net profit margin increased by 0.88% in 2022.

Headquarters
Szel u. 21.
Budapest; Budapest; Postal Code: 1035

Contact Details: Purchase the Kern es Tarsai Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Kern es Tarsai Bt. report to view the information.
Outstanding Shares:
Purchase the Kern es Tarsai Bt. report to view the information.
Registered Capital:
Purchase the Kern es Tarsai Bt. report to view the information.
Financial Auditors:
Purchase the Kern es Tarsai Bt. report to view the information.
Incorporation Date:
June 23, 1993
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Kern es Tarsai Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.1%▲
Total operating revenue
7.04%▲
Operating profit (EBIT)
28.78%▲
EBITDA
31.45%▲
Net Profit (Loss) for the Period
30.86%▲
Total assets
-8.84%▼
Total equity
29.54%▲
Operating Profit Margin (ROS)
0.88%▲
Net Profit Margin
0.88%▲
Return on Equity (ROE)
0.98%▲
Quick Ratio
-0.08%▼
Cash Ratio
-0.18%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo